98%
921
2 minutes
20
Background: There is a paucity of knowledge concerning the relationship between exposure to various pathogens and depression in adults residing in the United States. The objective of the study was to examine the prevalence and severity of depression in populations at risk of viral infections and to investigate the potential association between these two factors.
Methods: This study was derived from the National Health and Nutrition Examination Survey (NHANES), which included 39,749 participants aged 20 years or older between 2005 and 2018. The Patient Health Questionnaire-9 (PHQ-9) was employed to assess the presence and severity of depressive symptoms. Multivariable logistic regression analyses were conducted to evaluate the odds ratios and associations between viral seropositivity and depression.
Results: Significant associations were observed between seropositivity for hepatitis A virus (HAV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), human papillomavirus (HPV) types 6, 11, 16, and 18, and herpes simplex virus (HSV) type 2 and an increased risk of depression (all p-values < 0.05). No significant associations were observed for hepatitis B virus (HBV), hepatitis D virus (HDV), hepatitis E virus (HEV), or HSV type 1.
Conclusions: Seropositivity for HPV types 6, 11, 16, and 18, HAV, HCV, HIV, and HSV-2 was significantly associated with depression in a representative sample of U.S. adults.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.psychres.2025.116627 | DOI Listing |
mBio
September 2025
Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.
Accurate timing estimates of when participants acquire HIV in HIV prevention trials are necessary for determining antibody levels at acquisition. The Antibody-Mediated Prevention (AMP) Studies showed that a passively administered broadly neutralizing antibody can prevent the acquisition of HIV from a neutralization-sensitive virus. We developed a pipeline for estimating the date of detectable HIV acquisition (DDA) in AMP Study participants using diagnostic and viral sequence data.
View Article and Find Full Text PDFJ Viral Hepat
October 2025
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Discontinuing antivirals in chronic hepatitis B virus (HBV) 'e' antigen negative infection can enhance HBV surface antigen (HBsAg) loss but risks complications. We modelled the clinical impact of discontinuing antivirals in chronic HBV. We developed a Markov state model with Monte Carlo simulation of chronic HBV to compare continuation of antiviral therapy with 3 strategies of cessation and reinitiation for: (1) virologic relapse, (2) clinical relapse, or (3) hepatitis flare.
View Article and Find Full Text PDFJ Viral Hepat
October 2025
Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
Hepatitis B virus (HBV) infection is a global health challenge, with the World Health Organization (WHO) targeting its elimination by 2030. Jordan lacks sufficient data on HBV epidemiology, including prevalence, incidence and clearance. This study addresses these gaps through a retrospective analysis of HBV testing data from 40,268 individuals collected at Biolab Diagnostic Laboratories (2010-2024).
View Article and Find Full Text PDFBackground: Cytomegalovirus (CMV) viremia is a critical concern and known by the presence of the virus DNA in the blood, which poses sever risks and develops many complications in immuno-compromised patients. When CMV is untreated, it can cause pneumonitis, colitis, hepatitis, and encephalitis. Current diagnosis relies on molecular methods with qPCR as the preferred method.
View Article and Find Full Text PDFJ Viral Hepat
October 2025
Department of Obstetrics and Gynecology, the Second Hospital of Nanjing, and Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
Hepatitis B virus (HBV) infection is a serious public health concern worldwide, especially during pregnancy due to the associated health risks for the mother and fetus. This study aimed to explore the relationship between alanine aminotransferase (ALT) levels, age and HBV DNA levels in pregnant women with chronic HBV infection. Our cohort study included 1743 pregnant women with HBV who gave birth from January 2021 to June 2024.
View Article and Find Full Text PDF